Advances in Personalized Diagnosis and Treatment of Ophthalmic Diseases

A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Methodology, Drug and Device Discovery".

Deadline for manuscript submissions: 15 February 2025 | Viewed by 1037

Special Issue Editor


E-Mail Website
Guest Editor
1. Lahey Department of Surgery, Division of Ophthalmology, UMass Chan Medical School, University of Massachusetts, Burlington, MA 01805, USA
2. Department of Ophthalmology, Tufts University School of Medicine, Boston, MA 02111, USA
3. Graduate Faculty, The New England College of Optometry, Boston, MA 02215, USA
Interests: ophthalmology

Special Issue Information

Dear Colleagues,

The Journal of Personalized Medicine is pleased to announce a Special Issue on "Advances in Personalized Diagnosis and Treatment of Ophthalmic Diseases". This Special Issue aims to showcase cutting-edge research, innovative approaches, and significant developments in the field of personalized medicine applied to ophthalmology.

For this Special Issue, we invite original research, commentaries, and reviews that explore various aspects of personalized approaches in ophthalmology. The scope of the Special Issue includes, but is not limited to, the following topics:

  • Integration of genetic, molecular, and imaging biomarkers for individualized disease risk assessment and precise diagnosis;
  • Innovative diagnostic imaging techniques and technologies for improved disease characterization to improve patient outcomes in ophthalmic diseases;
  • Role of artificial intelligence and machine learning in personalized ophthalmology;
  • Digital health technologies for remote monitoring and personalized disease management for teleophthalmology;
  • Individualized drug delivery systems or treatment paradigms for enhanced treatment outcomes;
  • Social and policy implications of personalized medicine in ophthalmology.

By contributing to this Special Issue, authors will have the opportunity to showcase their work in an international, peer-reviewed, open access journal that emphasizes the translation of personalized medicine principles into clinical practice. JPM offers a rapid review process and high visibility, ensuring that accepted manuscripts reach a wide readership.

Dr. David Ramsey
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • personalized ophthalmology
  • ophthalmic imaging
  • biomarkers
  • artificial intelligence
  • digital health

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

10 pages, 218 KiB  
Review
Surgical and Non-Surgical Approach for Tear Trough Correction: Fat Repositioning Versus Hyaluronic Acid Fillers
by Stylianos Christodoulou, Argyrios Tzamalis, Ioannis Tsinopoulos and Nikolaos Ziakas
J. Pers. Med. 2024, 14(11), 1096; https://doi.org/10.3390/jpm14111096 - 6 Nov 2024
Viewed by 552
Abstract
Objective: This paper compares two popular techniques for tear trough correction—fat repositioning and hyaluronic acid (HA) fillers—highlighting their efficacy, safety profiles, patient satisfaction, and associated complications. Methods: A narrative review of 20 studies comparing fat repositioning and HA fillers was conducted, [...] Read more.
Objective: This paper compares two popular techniques for tear trough correction—fat repositioning and hyaluronic acid (HA) fillers—highlighting their efficacy, safety profiles, patient satisfaction, and associated complications. Methods: A narrative review of 20 studies comparing fat repositioning and HA fillers was conducted, focusing on parameters such as duration of results, volume restoration, complication rates, and patient satisfaction. Results: Fat repositioning provides long-lasting results but carries higher surgical risks compared with HA fillers. The transconjunctival approach is suitable for patients with minimal skin excess. The supraperiosteal plane allows for a quicker procedure and, despite postoperative edema and temporary irregular contouring, shows no difference in final cosmetic outcomes compared with other planes. Internal fixation reduces the risk of fat relapse and skin scarring but carries the risk of suboptimal positioning. HA fillers offer immediate, minimally invasive results but require periodic maintenance. The use of a cannula reduces the risk of vascular occlusion. Combining a high G’ filler for the midface with a low G’ with low hydrophilicity for the tear trough reduces the amount of filler needed and prolongs the results. Both surgical and non-surgical methods are effective, depending on patient needs and anatomical considerations. Conclusions: Fat repositioning is ideal for patients seeking long-term correction and are willing to undergo surgery, while HA fillers suit those preferring non-invasive treatments with customizable, short-term effects. Both techniques have pros and cons that must be matched to patient goals and conditions. Full article
Back to TopTop